Forte Biosciences, Inc.Forte Biosciences, Inc.Forte Biosciences, Inc.

Forte Biosciences, Inc.

No trades
See on Supercharts
Market capitalization
‪26.93 M‬USD
−1.1687USD
‪−31.48 M‬USD
‪29.35 M‬
Beta (1Y)
0.98

About Forte Biosciences, Inc.

CEO
Paul A. Wagner
Headquarters
Dallas
Employees (FY)
9
Founded
2017
ISIN
US34962G1094
FIGI
BBG001J2N4H0
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of FBRX is 0.7800 USD — it has increased by 5.41% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Forte Biosciences, Inc. stocks are traded under the ticker FBRX.
Forte Biosciences, Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
FBRX stock is 6.91% volatile and has beta coefficient of 0.98. Check out the list of the most volatile stocks — is Forte Biosciences, Inc. there?
One year price forecast for Forte Biosciences, Inc. has a max estimate of 3.0000 USD and a min estimate of 2.7500 USD.
FBRX earnings for the last quarter are −0.26 USD whereas the estimation was −0.57 USD which accounts for 54.39% surprise. Estimated earnings for the next quarter are −0.28 USD. See more details about Forte Biosciences, Inc. earnings.
Forte Biosciences, Inc. revenue for the last quarter amounts to ‪9.00 K‬ USD despite the estimated figure of ‪101.80 K‬ USD. In the next quarter revenue is expected to reach ‪1.80 K‬ USD.
Yes, you can track Forte Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
FBRX stock has risen by 6.85% compared to the previous week, the month change is a 20.00% rise, over the last year Forte Biosciences, Inc. has showed a 25.71% decrease.
FBRX net income for the last quarter is ‪−5.87 M‬ USD, while the quarter before that showed ‪−9.96 M‬ USD of net income which accounts for 41.01% change. Track more Forte Biosciences, Inc. financial stats to get the full picture.
Today Forte Biosciences, Inc. has the market capitalization of ‪26.93 M‬, it has decreased by 2.31% over the last week.
No, FBRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, FBRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Forte Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
FBRX reached its all-time high on May 8, 2017 with the price of 269.2920 USD, and its all-time low was 0.3800 USD and was reached on Nov 14, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 9.00 employees. See our rating of the largest employees — is Forte Biosciences, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Forte Biosciences, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Forte Biosciences, Inc. stock shows the sell signal. See more of Forte Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Forte Biosciences, Inc. future price: according to them, FBRX price has a max estimate of 3.00 USD and a min estimate of 2.75 USD. Read a more detailed Forte Biosciences, Inc. forecast: see what analysts think of Forte Biosciences, Inc. and suggest that you do with its stocks.